APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Drug Discovery AI Tools

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Drug Discovery AI Tools Market Analysis and Forecast 2026-2032

Report ID 174554680512 August 2026170 pages

Choose your research edition.

Industry ResearchDrug Discovery AI Tools Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Discovery AI Tools Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Drug Discovery AI Tools Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Discovery AI Tools Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Discovery AI Tools Market Analysis and Forecast 2026-2032170 pages · $4,950 USD

Market perspective

The global Drug Discovery AI Tools market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Drug Discovery AI Tools is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Drug Discovery AI Tools is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Drug Discovery AI Tools is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Drug Discovery AI Tools is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Drug Discovery AI Tools include Exscientia, Insilico Medicine, Valo Health, Owkin, XtalPi, Healx, Atomwise, BenevolentAI and Recursion, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Drug Discovery AI Tools, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Drug Discovery AI Tools, also provides the revenue of main regions and countries. Of the upcoming market potential for Drug Discovery AI Tools, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drug Discovery AI Tools revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Drug Discovery AI Tools market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Drug Discovery AI Tools revenue, projected growth trends, production technology, application and end-user industry.

Drug Discovery AI Tools Segment by Company

Exscientia

Insilico Medicine

Valo Health

Owkin

XtalPi

Healx

Atomwise

BenevolentAI

Recursion

Drug Discovery AI Tools Segment by Type

Drug Target Identification

Compound Screening

Efficacy Prediction

Clinical Trial Optimization

Drug Discovery AI Tools Segment by Application

Contract Research Organizations

Research Centers and Academic Institutes

Pharmaceutical and Biotechnology Companies

Drug Discovery AI Tools Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Discovery AI Tools market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Discovery AI Tools and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Discovery AI Tools.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Drug Discovery AI Tools in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Drug Discovery AI Tools company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Discovery AI Tools revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drug Discovery AI Tools Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Drug Target Identification Major Player Table 3. Compound Screening Major Player Table 4. Efficacy Prediction Major Player Table 5. Clinical Trial Optimization Major Player Table 6. Global Drug Discovery AI Tools Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Contract Research Organizations Major Player Table 8. Research Centers and Academic Institutes Major Player Table 9. Pharmaceutical and Biotechnology Companies Major Player Table 10. Drug Discovery AI Tools Industry Trends Table 11. Drug Discovery AI Tools Industry Drivers Table 12. Drug Discovery AI Tools Industry Opportunities and Challenges Table 13. Drug Discovery AI Tools Industry Restraints Table 14. Global Drug Discovery AI Tools Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Drug Discovery AI Tools Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Drug Discovery AI Tools Market Share by Region (2021-2026) Table 17. Global Drug Discovery AI Tools Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Drug Discovery AI Tools Market Share by Region (2027-2032) Table 19. Global Drug Discovery AI Tools Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Drug Discovery AI Tools Revenue Market Share by Players (2021-2026) Table 21. Global Drug Discovery AI Tools Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Drug Discovery AI Tools Key Players Headquarters & Area Served Table 23. Global Drug Discovery AI Tools Players, Product Type & Application Table 24. Global Drug Discovery AI Tools Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Drug Discovery AI Tools by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Drug Discovery AI Tools Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Drug Discovery AI Tools Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Drug Discovery AI Tools Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Drug Discovery AI Tools Revenue Market Share by Type (2021-2026) Table 31. Global Drug Discovery AI Tools Revenue Market Share by Type (2027-2032) Table 32. Global Drug Discovery AI Tools Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Drug Discovery AI Tools Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Drug Discovery AI Tools Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Drug Discovery AI Tools Revenue Market Share by Application (2021-2026) Table 36. Global Drug Discovery AI Tools Revenue Market Share by Application (2027-2032) Table 37. Exscientia Company Information Table 38. Exscientia Business Overview Table 39. Exscientia Drug Discovery AI Tools Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Exscientia Drug Discovery AI Tools Product Portfolio Table 41. Exscientia Recent Development Table 42. Insilico Medicine Company Information Table 43. Insilico Medicine Business Overview Table 44. Insilico Medicine Drug Discovery AI Tools Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Insilico Medicine Drug Discovery AI Tools Product Portfolio Table 46. Insilico Medicine Recent Development Table 47. Valo Health Company Information Table 48. Valo Health Business Overview Table 49. Valo Health Drug Discovery AI Tools Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Valo Health Drug Discovery AI Tools Product Portfolio Table 51. Valo Health Recent Development Table 52. Owkin Company Information Table 53. Owkin Business Overview Table 54. Owkin Drug Discovery AI Tools Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Owkin Drug Discovery AI Tools Product Portfolio Table 56. Owkin Recent Development Table 57. XtalPi Company Information Table 58. XtalPi Business Overview Table 59. XtalPi Drug Discovery AI Tools Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. XtalPi Drug Discovery AI Tools Product Portfolio Table 61. XtalPi Recent Development Table 62. Healx Company Information Table 63. Healx Business Overview Table 64. Healx Drug Discovery AI Tools Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Healx Drug Discovery AI Tools Product Portfolio Table 66. Healx Recent Development Table 67. Atomwise Company Information Table 68. Atomwise Business Overview Table 69. Atomwise Drug Discovery AI Tools Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Atomwise Drug Discovery AI Tools Product Portfolio Table 71. Atomwise Recent Development Table 72. BenevolentAI Company Information Table 73. BenevolentAI Business Overview Table 74. BenevolentAI Drug Discovery AI Tools Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. BenevolentAI Drug Discovery AI Tools Product Portfolio Table 76. BenevolentAI Recent Development Table 77. Recursion Company Information Table 78. Recursion Business Overview Table 79. Recursion Drug Discovery AI Tools Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Recursion Drug Discovery AI Tools Product Portfolio Table 81. Recursion Recent Development Table 82. North America Drug Discovery AI Tools Revenue by Type (2021-2026) & (US$ Million) Table 83. North America Drug Discovery AI Tools Revenue by Type (2027-2032) & (US$ Million) Table 84. North America Drug Discovery AI Tools Revenue by Application (2021-2026) & (US$ Million) Table 85. North America Drug Discovery AI Tools Revenue by Application (2027-2032) & (US$ Million) Table 86. North America Drug Discovery AI Tools Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. North America Drug Discovery AI Tools Revenue by Country (2021-2026) & (US$ Million) Table 88. North America Drug Discovery AI Tools Revenue by Country (US$ Million) & (2027-2032) Table 89. Europe Drug Discovery AI Tools Revenue by Type (2021-2026) & (US$ Million) Table 90. Europe Drug Discovery AI Tools Revenue by Type (2027-2032) & (US$ Million) Table 91. Europe Drug Discovery AI Tools Revenue by Application (2021-2026) & (US$ Million) Table 92. Europe Drug Discovery AI Tools Revenue by Application (2027-2032) & (US$ Million) Table 93. Europe Drug Discovery AI Tools Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. Europe Drug Discovery AI Tools Revenue by Country (2021-2026) & (US$ Million) Table 95. Europe Drug Discovery AI Tools Revenue by Country (US$ Million) & (2027-2032) Table 96. China Drug Discovery AI Tools Revenue by Type (2021-2026) & (US$ Million) Table 97. China Drug Discovery AI Tools Revenue by Type (2027-2032) & (US$ Million) Table 98. China Drug Discovery AI Tools Revenue by Application (2021-2026) & (US$ Million) Table 99. China Drug Discovery AI Tools Revenue by Application (2027-2032) & (US$ Million) Table 100. Asia Drug Discovery AI Tools Revenue by Type (2021-2026) & (US$ Million) Table 101. Asia Drug Discovery AI Tools Revenue by Type (2027-2032) & (US$ Million) Table 102. Asia Drug Discovery AI Tools Revenue by Application (2021-2026) & (US$ Million) Table 103. Asia Drug Discovery AI Tools Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Drug Discovery AI Tools Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 105. Asia Drug Discovery AI Tools Revenue by Region (US$ Million) & (2021-2026) Table 106. Asia Drug Discovery AI Tools Revenue by Region (US$ Million) & (2027-2032) Table 107. SAMEA Drug Discovery AI Tools Revenue by Type (2021-2026) & (US$ Million) Table 108. SAMEA Drug Discovery AI Tools Revenue by Type (2027-2032) & (US$ Million) Table 109. SAMEA Drug Discovery AI Tools Revenue by Application (2021-2026) & (US$ Million) Table 110. SAMEA Drug Discovery AI Tools Revenue by Application (2027-2032) & (US$ Million) Table 111. SAMEA Drug Discovery AI Tools Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. SAMEA Drug Discovery AI Tools Revenue by Country (2021-2026) & (US$ Million) Table 113. SAMEA Drug Discovery AI Tools Revenue by Country (US$ Million) & (2027-2032) Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Drug Discovery AI Tools Image Figure 2. Global Drug Discovery AI Tools Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Discovery AI Tools Market Size Share 2021 VS 2025 VS 2032 Figure 4. Drug Target Identification Image Figure 5. Compound Screening Image Figure 6. Efficacy Prediction Image Figure 7. Clinical Trial Optimization Image Figure 8. Global Drug Discovery AI Tools Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Drug Discovery AI Tools Market Size Share 2021 VS 2025 VS 2032 Figure 10. Contract Research Organizations Image Figure 11. Research Centers and Academic Institutes Image Figure 12. Pharmaceutical and Biotechnology Companies Image Figure 13. Global Drug Discovery AI Tools Market Size (US$ Million) & (2021-2032) Figure 14. Global Drug Discovery AI Tools Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Drug Discovery AI Tools Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Drug Discovery AI Tools Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Drug Discovery AI Tools Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Drug Discovery AI Tools Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Drug Discovery AI Tools Revenue Market Share by Type (2021-2032) Figure 21. Global Drug Discovery AI Tools Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Drug Discovery AI Tools Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Drug Discovery AI Tools Revenue Market Share by Application (2021-2032) Figure 24. North America Drug Discovery AI Tools Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Drug Discovery AI Tools Revenue Share by Type (2021-2032) Figure 26. North America Drug Discovery AI Tools Revenue Share by Application (2021-2032) Figure 27. North America Drug Discovery AI Tools Revenue Share by Country (2021-2032) Figure 28. United States Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Drug Discovery AI Tools Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Drug Discovery AI Tools Revenue Share by Type (2021-2032) Figure 33. Europe Drug Discovery AI Tools Revenue Share by Application (2021-2032) Figure 34. Europe Drug Discovery AI Tools Revenue Share by Country (2021-2032) Figure 35. Germany Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Drug Discovery AI Tools Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Drug Discovery AI Tools Revenue Share by Type (2021-2032) Figure 45. China Drug Discovery AI Tools Revenue Share by Application (2021-2032) Figure 46. Asia Drug Discovery AI Tools Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Drug Discovery AI Tools Revenue Share by Type (2021-2032) Figure 48. Asia Drug Discovery AI Tools Revenue Share by Application (2021-2032) Figure 49. Asia Drug Discovery AI Tools Revenue Share by Region (2021-2032) Figure 50. Japan Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Drug Discovery AI Tools Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Drug Discovery AI Tools Revenue Share by Type (2021-2032) Figure 58. SAMEA Drug Discovery AI Tools Revenue Share by Application (2021-2032) Figure 59. SAMEA Drug Discovery AI Tools Revenue Share by Country (2021-2032) Figure 60. Brazil Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Drug Discovery AI Tools Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Drug Target Identification
  • Compound Screening
  • Efficacy Prediction
  • Clinical Trial Optimization
Applications
  • Contract Research Organizations
  • Research Centers and Academic Institutes
  • Pharmaceutical and Biotechnology Companies
Companies covered
  • Exscientia
  • Insilico Medicine
  • Valo Health
  • Owkin
  • XtalPi
  • Healx
  • Atomwise
  • BenevolentAI
  • Recursion

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Drug Discovery AI Tools Market by Type
  3. 1.2.1 Global Drug Discovery AI Tools Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Drug Target Identification
  5. 1.2.3 Compound Screening
  6. 1.2.4 Efficacy Prediction
  7. 1.2.5 Clinical Trial Optimization
  8. 1.3 Drug Discovery AI Tools Market by Application
  9. 1.3.1 Global Drug Discovery AI Tools Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Contract Research Organizations
  11. 1.3.3 Research Centers and Academic Institutes
  12. 1.3.4 Pharmaceutical and Biotechnology Companies
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Drug Discovery AI Tools Market Dynamics
  1. 2.1 Drug Discovery AI Tools Industry Trends
  2. 2.2 Drug Discovery AI Tools Industry Drivers
  3. 2.3 Drug Discovery AI Tools Industry Opportunities and Challenges
  4. 2.4 Drug Discovery AI Tools Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Drug Discovery AI Tools Market Perspective (2021-2032)
  2. 3.2 Global Drug Discovery AI Tools Growth Trends by Region
  3. 3.2.1 Global Drug Discovery AI Tools Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Drug Discovery AI Tools Market Size by Region (2021-2026)
  5. 3.2.3 Global Drug Discovery AI Tools Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Drug Discovery AI Tools Revenue by Players
  2. 4.1.1 Global Drug Discovery AI Tools Revenue by Players (2021-2026)
  3. 4.1.2 Global Drug Discovery AI Tools Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Drug Discovery AI Tools Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Drug Discovery AI Tools Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Drug Discovery AI Tools Key Players Headquarters & Area Served
  7. 4.4 Global Drug Discovery AI Tools Players, Product Type & Application
  8. 4.5 Global Drug Discovery AI Tools Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Drug Discovery AI Tools Market CR5 and HHI
  11. 4.6.3 2025 Drug Discovery AI Tools Tier 1, Tier 2, and Tier 3
5 Drug Discovery AI Tools Market Size by Type
  1. 5.1 Global Drug Discovery AI Tools Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Drug Discovery AI Tools Revenue by Type (2021-2032)
  3. 5.3 Global Drug Discovery AI Tools Revenue Market Share by Type (2021-2032)
6 Drug Discovery AI Tools Market Size by Application
  1. 6.1 Global Drug Discovery AI Tools Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Drug Discovery AI Tools Revenue by Application (2021-2032)
  3. 6.3 Global Drug Discovery AI Tools Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Exscientia
  2. 7.1.1 Exscientia Company Information
  3. 7.1.2 Exscientia Business Overview
  4. 7.1.3 Exscientia Drug Discovery AI Tools Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Exscientia Drug Discovery AI Tools Product Portfolio
  6. 7.1.5 Exscientia Recent Developments
  7. 7.2 Insilico Medicine
  8. 7.2.1 Insilico Medicine Company Information
  9. 7.2.2 Insilico Medicine Business Overview
  10. 7.2.3 Insilico Medicine Drug Discovery AI Tools Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Insilico Medicine Drug Discovery AI Tools Product Portfolio
  12. 7.2.5 Insilico Medicine Recent Developments
  13. 7.3 Valo Health
  14. 7.3.1 Valo Health Company Information
  15. 7.3.2 Valo Health Business Overview
  16. 7.3.3 Valo Health Drug Discovery AI Tools Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Valo Health Drug Discovery AI Tools Product Portfolio
  18. 7.3.5 Valo Health Recent Developments
  19. 7.4 Owkin
  20. 7.4.1 Owkin Company Information
  21. 7.4.2 Owkin Business Overview
  22. 7.4.3 Owkin Drug Discovery AI Tools Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Owkin Drug Discovery AI Tools Product Portfolio
  24. 7.4.5 Owkin Recent Developments
  25. 7.5 XtalPi
  26. 7.5.1 XtalPi Company Information
  27. 7.5.2 XtalPi Business Overview
  28. 7.5.3 XtalPi Drug Discovery AI Tools Revenue and Gross Margin (2021-2026)
  29. 7.5.4 XtalPi Drug Discovery AI Tools Product Portfolio
  30. 7.5.5 XtalPi Recent Developments
  31. 7.6 Healx
  32. 7.6.1 Healx Company Information
  33. 7.6.2 Healx Business Overview
  34. 7.6.3 Healx Drug Discovery AI Tools Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Healx Drug Discovery AI Tools Product Portfolio
  36. 7.6.5 Healx Recent Developments
  37. 7.7 Atomwise
  38. 7.7.1 Atomwise Company Information
  39. 7.7.2 Atomwise Business Overview
  40. 7.7.3 Atomwise Drug Discovery AI Tools Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Atomwise Drug Discovery AI Tools Product Portfolio
  42. 7.7.5 Atomwise Recent Developments
  43. 7.8 BenevolentAI
  44. 7.8.1 BenevolentAI Company Information
  45. 7.8.2 BenevolentAI Business Overview
  46. 7.8.3 BenevolentAI Drug Discovery AI Tools Revenue and Gross Margin (2021-2026)
  47. 7.8.4 BenevolentAI Drug Discovery AI Tools Product Portfolio
  48. 7.8.5 BenevolentAI Recent Developments
  49. 7.9 Recursion
  50. 7.9.1 Recursion Company Information
  51. 7.9.2 Recursion Business Overview
  52. 7.9.3 Recursion Drug Discovery AI Tools Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Recursion Drug Discovery AI Tools Product Portfolio
  54. 7.9.5 Recursion Recent Developments
8 North America
  1. 8.1 North America Drug Discovery AI Tools Revenue (2021-2032)
  2. 8.2 North America Drug Discovery AI Tools Revenue by Type (2021-2032)
  3. 8.2.1 North America Drug Discovery AI Tools Revenue by Type (2021-2026)
  4. 8.2.2 North America Drug Discovery AI Tools Revenue by Type (2027-2032)
  5. 8.3 North America Drug Discovery AI Tools Revenue Share by Type (2021-2032)
  6. 8.4 North America Drug Discovery AI Tools Revenue by Application (2021-2032)
  7. 8.4.1 North America Drug Discovery AI Tools Revenue by Application (2021-2026)
  8. 8.4.2 North America Drug Discovery AI Tools Revenue by Application (2027-2032)
  9. 8.5 North America Drug Discovery AI Tools Revenue Share by Application (2021-2032)
  10. 8.6 North America Drug Discovery AI Tools Revenue by Country
  11. 8.6.1 North America Drug Discovery AI Tools Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Drug Discovery AI Tools Revenue by Country (2021-2026)
  13. 8.6.3 North America Drug Discovery AI Tools Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Drug Discovery AI Tools Revenue (2021-2032)
  2. 9.2 Europe Drug Discovery AI Tools Revenue by Type (2021-2032)
  3. 9.2.1 Europe Drug Discovery AI Tools Revenue by Type (2021-2026)
  4. 9.2.2 Europe Drug Discovery AI Tools Revenue by Type (2027-2032)
  5. 9.3 Europe Drug Discovery AI Tools Revenue Share by Type (2021-2032)
  6. 9.4 Europe Drug Discovery AI Tools Revenue by Application (2021-2032)
  7. 9.4.1 Europe Drug Discovery AI Tools Revenue by Application (2021-2026)
  8. 9.4.2 Europe Drug Discovery AI Tools Revenue by Application (2027-2032)
  9. 9.5 Europe Drug Discovery AI Tools Revenue Share by Application (2021-2032)
  10. 9.6 Europe Drug Discovery AI Tools Revenue by Country
  11. 9.6.1 Europe Drug Discovery AI Tools Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Drug Discovery AI Tools Revenue by Country (2021-2026)
  13. 9.6.3 Europe Drug Discovery AI Tools Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Drug Discovery AI Tools Revenue (2021-2032)
  2. 10.2 China Drug Discovery AI Tools Revenue by Type (2021-2032)
  3. 10.2.1 China Drug Discovery AI Tools Revenue by Type (2021-2026)
  4. 10.2.2 China Drug Discovery AI Tools Revenue by Type (2027-2032)
  5. 10.3 China Drug Discovery AI Tools Revenue Share by Type (2021-2032)
  6. 10.4 China Drug Discovery AI Tools Revenue by Application (2021-2032)
  7. 10.4.1 China Drug Discovery AI Tools Revenue by Application (2021-2026)
  8. 10.4.2 China Drug Discovery AI Tools Revenue by Application (2027-2032)
  9. 10.5 China Drug Discovery AI Tools Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Drug Discovery AI Tools Revenue (2021-2032)
  2. 11.2 Asia Drug Discovery AI Tools Revenue by Type (2021-2032)
  3. 11.2.1 Asia Drug Discovery AI Tools Revenue by Type (2021-2026)
  4. 11.2.2 Asia Drug Discovery AI Tools Revenue by Type (2027-2032)
  5. 11.3 Asia Drug Discovery AI Tools Revenue Share by Type (2021-2032)
  6. 11.4 Asia Drug Discovery AI Tools Revenue by Application (2021-2032)
  7. 11.4.1 Asia Drug Discovery AI Tools Revenue by Application (2021-2026)
  8. 11.4.2 Asia Drug Discovery AI Tools Revenue by Application (2027-2032)
  9. 11.5 Asia Drug Discovery AI Tools Revenue Share by Application (2021-2032)
  10. 11.6 Asia Drug Discovery AI Tools Revenue by Country
  11. 11.6.1 Asia Drug Discovery AI Tools Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Drug Discovery AI Tools Revenue by Country (2021-2026)
  13. 11.6.3 Asia Drug Discovery AI Tools Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Drug Discovery AI Tools Revenue (2021-2032)
  2. 12.2 SAMEA Drug Discovery AI Tools Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Drug Discovery AI Tools Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Drug Discovery AI Tools Revenue by Type (2027-2032)
  5. 12.3 SAMEA Drug Discovery AI Tools Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Drug Discovery AI Tools Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Drug Discovery AI Tools Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Drug Discovery AI Tools Revenue by Application (2027-2032)
  9. 12.5 SAMEA Drug Discovery AI Tools Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Drug Discovery AI Tools Revenue by Country
  11. 12.6.1 SAMEA Drug Discovery AI Tools Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Drug Discovery AI Tools Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Drug Discovery AI Tools Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst